Panacea shows interest in the Covaxin production
Panacea Biotec seems to be interested in producing the Covaxin vaccine. Sources said Panacea hopes to enter into an agreement with Bharat Biotech to produce Covaxin at the company's unit in Delhi, and talks are at an early stage.
It also seems that the two companies want the government to provide funding to increase production capacity. Panacea is said to be ready to produce covaxin in two to three months if it receives funding from the government. Panacea has the Biosafety Level 3 manufacturing unit which is needed to make the coronavirus vaccine.